Company News
FDA LDT Rule Overturned—Important Update for Your Lab
Important Regulatory Update: On March 31, 2025, the U.S. District Court for the Eastern District of Texas vacated the FDA’s Final Rule concerning Laboratory Developed Tests (LDTs). This decision effectively removes FDA-imposed restrictions and reaffirms the oversight of LDTs under CLIA regulations managed by CMS. What does this mean for your lab? Continuing Use of […]
Empire Genomics Corp Awarded Molecular Agreement with Premier GPO!
Buffalo, New York – April 1, 2024 – Empire Genomics Corp has been awarded a national group purchasing agreement for Molecular Analyzers, Reagents with Premier, Inc. Effective 02/01/2024, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for FISH (Fluorescent in situ Hybridization) Probes. “Empire […]
